Zhongbo Juli

Null Hypothesis is an AI-driven medical software as a service (SaaS) company dedicated to creating intelligent medical products. The firm specializes in leveraging artificial intelligence-generated content (AIGC) to enhance the development and commercialization of innovative drugs. By integrating advanced data technology with medical expertise, Null Hypothesis aims to streamline knowledge transfer processes within the academic and pharmaceutical sectors, promoting efficiency and professionalism throughout the drug development chain.

Shenji Changhua is a biotechnology company focusing on neurological diseases such as ALS.

Wuhan Binhui Biotechnology Co., Ltd., established in 2010 and headquartered in Wuhan, China, specializes in the development of virus injection preparations. Situated in the Optics Valley Bio City within the Donghu National Independent Innovation Demonstration Zone, the company focuses on creating innovative products and services in the oncology sector, encompassing both diagnosis and treatment. Binhui Biotech is dedicated to developing offerings with independent intellectual property rights, aiming to compete effectively on the international market.

HemaCell is a biotechnology company specializing in cell therapy, specifically focused on regenerating hematopoietic lineages, which include blood and immune cells, through advanced in vitro techniques. Leveraging innovative stem cell reprogramming, editing, and differentiation technologies, HemaCell aims to address the critical shortage of platelets necessary for treating various diseases such as cancer, liver disease, critical illness, and hematological disorders. The company employs a unique platform that utilizes platelets as drug delivery carriers, facilitating the rapid establishment of induced pluripotent stem cells (iPSCs) and gene targeting technologies. In addition to platelet production, HemaCell is dedicated to developing novel therapeutic solutions for diseases associated with platelet abnormalities, thereby offering effective treatment options and addressing significant medical needs.

Linkwise Technology is a semiconductor company specializing in material handling automation systems (AMHS) tailored for semiconductor production logistics. The company develops innovative semiconductor packaging and testing technologies, focusing on creating customized automation solutions. Its services encompass the planning and design of automation systems for semiconductor production lines, the design and production of automated logistics handling equipment, and the development of software control systems. Additionally, Linkwise Technology is involved in the intelligent transformation of production equipment and processes, helping customers optimize manufacturing efficiency, enhance product yield, reduce production costs, and save on human capital.

Zenosic focuses in the design and R&D of high-performance network chips, along with offering leading chip products for cloud service providers, equipment makers, operators, and diverse industries.

Innolake Biopharm is a clinical-stage biotechnology company specializing in the development of therapeutic drugs for oncology and autoimmune diseases. The company focuses on overcoming challenges associated with tumors and immune system disorders through innovative research and development. With an extensive product development pipeline, Innolake Biopharm aims to enhance treatment options for patients, improving their health outcomes and overall quality of life.

Boruspan is a machine tool manufacturing enterprise, engaged in the R&D and manufacturing of high-precision CNC machine tools.

Immunophage Biotech, established in 2016, is a Chinese pharmaceutical company dedicated to new drug development. Based in Nanjing, with its R&D center in Shanghai's Pujiang High-Tech Park, the company focuses on creating first-in-class immune-regulating therapies for cancer, autoimmune diseases, and neurodegenerative disorders.

Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.

Picocom is a specialist in 5G open RAN baseband semiconductors and software, focused on designing and marketing products that comply with Open RAN standards. The company develops baseband system-on-chips (SoCs) and carrier-grade software tailored specifically for 5G small cell infrastructure. By providing advanced semiconductor solutions, Picocom aims to enhance the capabilities and performance of 5G networks for industry users.

Welink Vision is a 3D robot vision technology developer, focused on the R&D of cognitive robots, and integration of IT and RT technology.